Novel therapeutic strategies for adult obese asthmatics

Angela L. Linderholm, Jennifer M. Bratt, Gertrud U. Schuster, Amir Zeki, Nicholas Kenyon

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Asthma is a complex syndrome that affects an estimated 26 million people in the United States but gaps exist in the recognition and management of asthmatic subgroups. This article proposes alternative approaches for future treatments of adult obese asthmatics who do not respond to standard controller therapies, drawing parallels between seemingly disparate therapeutics through their common signaling pathways. How metformin and statins can potentially improve airway inflammation is described and supplements are suggested. A move toward more targeted therapies for asthma subgroups is needed. These therapies address asthma and the comorbidities that accompany obesity and metabolic syndrome to provide the greatest therapeutic potential.

Original languageEnglish (US)
Pages (from-to)809-823
Number of pages15
JournalImmunology and Allergy Clinics of North America
Volume34
Issue number4
DOIs
StatePublished - 2014

Fingerprint

Asthma
Therapeutics
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Metformin
Comorbidity
Obesity
Inflammation

Keywords

  • L-Arginine
  • Metformin
  • Nitric oxide
  • Obesity
  • Severe asthma
  • Statins

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Novel therapeutic strategies for adult obese asthmatics. / Linderholm, Angela L.; Bratt, Jennifer M.; Schuster, Gertrud U.; Zeki, Amir; Kenyon, Nicholas.

In: Immunology and Allergy Clinics of North America, Vol. 34, No. 4, 2014, p. 809-823.

Research output: Contribution to journalArticle

Linderholm, Angela L. ; Bratt, Jennifer M. ; Schuster, Gertrud U. ; Zeki, Amir ; Kenyon, Nicholas. / Novel therapeutic strategies for adult obese asthmatics. In: Immunology and Allergy Clinics of North America. 2014 ; Vol. 34, No. 4. pp. 809-823.
@article{0112d3fa9c6b443fa87723f44997367a,
title = "Novel therapeutic strategies for adult obese asthmatics",
abstract = "Asthma is a complex syndrome that affects an estimated 26 million people in the United States but gaps exist in the recognition and management of asthmatic subgroups. This article proposes alternative approaches for future treatments of adult obese asthmatics who do not respond to standard controller therapies, drawing parallels between seemingly disparate therapeutics through their common signaling pathways. How metformin and statins can potentially improve airway inflammation is described and supplements are suggested. A move toward more targeted therapies for asthma subgroups is needed. These therapies address asthma and the comorbidities that accompany obesity and metabolic syndrome to provide the greatest therapeutic potential.",
keywords = "L-Arginine, Metformin, Nitric oxide, Obesity, Severe asthma, Statins",
author = "Linderholm, {Angela L.} and Bratt, {Jennifer M.} and Schuster, {Gertrud U.} and Amir Zeki and Nicholas Kenyon",
year = "2014",
doi = "10.1016/j.iac.2014.07.006",
language = "English (US)",
volume = "34",
pages = "809--823",
journal = "Immunology and Allergy Clinics of North America",
issn = "0889-8561",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Novel therapeutic strategies for adult obese asthmatics

AU - Linderholm, Angela L.

AU - Bratt, Jennifer M.

AU - Schuster, Gertrud U.

AU - Zeki, Amir

AU - Kenyon, Nicholas

PY - 2014

Y1 - 2014

N2 - Asthma is a complex syndrome that affects an estimated 26 million people in the United States but gaps exist in the recognition and management of asthmatic subgroups. This article proposes alternative approaches for future treatments of adult obese asthmatics who do not respond to standard controller therapies, drawing parallels between seemingly disparate therapeutics through their common signaling pathways. How metformin and statins can potentially improve airway inflammation is described and supplements are suggested. A move toward more targeted therapies for asthma subgroups is needed. These therapies address asthma and the comorbidities that accompany obesity and metabolic syndrome to provide the greatest therapeutic potential.

AB - Asthma is a complex syndrome that affects an estimated 26 million people in the United States but gaps exist in the recognition and management of asthmatic subgroups. This article proposes alternative approaches for future treatments of adult obese asthmatics who do not respond to standard controller therapies, drawing parallels between seemingly disparate therapeutics through their common signaling pathways. How metformin and statins can potentially improve airway inflammation is described and supplements are suggested. A move toward more targeted therapies for asthma subgroups is needed. These therapies address asthma and the comorbidities that accompany obesity and metabolic syndrome to provide the greatest therapeutic potential.

KW - L-Arginine

KW - Metformin

KW - Nitric oxide

KW - Obesity

KW - Severe asthma

KW - Statins

UR - http://www.scopus.com/inward/record.url?scp=84922256032&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922256032&partnerID=8YFLogxK

U2 - 10.1016/j.iac.2014.07.006

DO - 10.1016/j.iac.2014.07.006

M3 - Article

C2 - 25282293

AN - SCOPUS:84922256032

VL - 34

SP - 809

EP - 823

JO - Immunology and Allergy Clinics of North America

JF - Immunology and Allergy Clinics of North America

SN - 0889-8561

IS - 4

ER -